토모테라피를 이용한 간암환자의 정위적 방사선치료시 복부압박장치의 유용성 평가
우중열, 김주호, 김준원 et al. · 2012
목 적: 간에 발생한 절제 불가능한 원발성 및 전이성 종양에서 토모테라피를 이용한 정위적 방사선치료를 시행하기 위해 사용된 복부압박장치의 유용성을 평가하고자 하였다. 대상 및 방법: 2011년 11월부터 2012년 3월까지 토모테라피(Hi-Art Tomotherapy, USA)를 시행받기 위해 본원에 내원한 간암환자 중 복부압박장치(diaphragm control, elekta, sweden)를 사용하였을 때 움직임이 1 cm 이상 줄어든 환자를 대상으로 하였다. 4D CT (somatom sensation, siemens, germany)를 통해 치료계획영상과 4차원 단층촬영영상을 촬영하고, 육안적으로 보이는 종양과 종양의 움직임을 고려하여 육안적 종양체적(gross tumor volume, GTV)으로 설정하였고, GTV 주변으로 균일하게 5~7 mm의 여유를 주어 치료계획용 종양체적(planning target volume, PTV)으로 설정하였다. 손상위험장기(organs at risk) 중 십이지장, 위, 대장의 거리가 종양으로부터 최소 1 cm 이상인 환자들을 1군( $d{\geq}1$ )으로, 1 cm 미만인 환자들을 2군(d $d{\geq}1$ )은 4회, 2군(d $V_{diff3%}$ )과 5%의 선량차이를 나타내는 체적( $V_{diff3%}$ )을 비교하였고, 손상위험장기 중 대장장기의 최대선량의 차이율을 비교하였다. 결 과: MVCT를 통해 분석한 평균 셋업오차는 $-0.66{\pm}1.53$ mm (좌-우), $0.39{\pm}4.17$ mm (상-하), $0.71{\pm}1.74$ mm (전-후), $-0.18{\pm}0.30$ degrees (roll)였다. 1군( $d{\geq}1$ )과 2군(d $d{\geq}1$ )에서 보정방사선 치료계획을 통한 $V_{diff3%}$ 중 GTV는 $0.78{\pm}0.05%$ , PTV는 $9.97{\pm}3.62%$ , $V_{diff5%}$ 중 GTV는 0.0%, PTV는 $2.9{\pm}0.95%$ , 대장장기의 최대선량의 차이율은 $-6.85{\pm}1.11%$ 였다. 2군(d $V_{diff3%}$ 중 GTV는 $1.62{\pm}0.55%$ , PTV는 $8.61{\pm}2.01%$ , $V_{diff5%}$ 중 GTV는 0.0%, PTV는 $5.33{\pm}2.32%$ , 대장장기의 최대선량의 차이율은 $28.33{\pm}24.41%$ 였다. 결 론: 복부압박장치를 통한 간암의 방사선치료시 MVCT를 통한 환자 셋업오차는 평균 ${\pm}5$ mm 이하였고, 복부 압박장치를 사용하고 투시영상을 통해 확인한 횡경막의 움직임이 최소 5 mm 이상이라는 것을 감안하면, 환자 셋업오차는 그 안에 있음을 알 수 있었다. 1군( $d{\geq}1$ )과 2군(d $d{\geq}1$ )과 2군(d $d{\geq}1$ )이 2군(d 【Purpose: We evaluated usefulness of abdominal compressor for stereotactic body radiotherapy (SBRT) with unresectable hepatocellular carcinoma (HCC) patients and hepato-biliary cancer and metastatic liver cancer patients. Materials and Methods: From November 2011 to March 2012, we selected HCC patients who gained reduction of diaphragm movement >1 cm through abdominal compressor (diaphragm control, elekta, sweden) for HT (Hi-Art Tomotherapy, USA). We got planning computed tomography (CT) images and 4 dimensional (4D) images through 4D CT (somatom sensation, siemens, germany). The gross tumor volume (GTV) included a gross tumor and margins considering tumor movement. The planning target volume (PTV) included a 5 to 7 mm safety margin around GTV. We classified patients into two groups according to distance between tumor and organs at risk (OAR, stomach, duodenum, bowel). Patients with the distance more than 1 cm are classified as the 1st group and they received SBRT of 4 or 5 fractions. Patients with the distance less than 1 cm are classified as the 2nd group and they received tomotherapy of 20 fractions. Megavoltage computed tomography (MVCT) were performed 4 or 10 fractions. When we verify a MVCT fusion considering priority to liver than bone-technique. We sent MVCT images to Mim_vista (Mimsoftware, ver .5.4. USA) and we re-delineated stomach, duodenum and bowel to bowel_organ and delineated liver. First, we analyzed MVCT images to check the setup variation. Second we compared dose difference between tumor and OAR based on adaptive dose through adaptive planning station and Mim_vista. Results: Average setup variation from MVCT was $-0.66{\pm}1.53$ mm (left-right) $0.39{\pm}4.17$ mm (superior-inferior), $0.71{\pm}1.74$ mm (anterior-posterior), $-0.18{\pm}0.30$ degrees (roll). 1st group ( $d{\geq}1$ ) and 2nd group (d $d{\geq}1$ ) of $V_{diff3%}$ (volume of 3% difference of dose) of GTV through adaptive planing station was $0.78{\pm}0.05%$ , PTV was $9.97{\pm}3.62%$ , $V_{diff5%}$ was GTV 0.0%, PTV was $2.9{\pm}0.95%$ , maximum dose difference rate of bowel_organ was $-6.85{\pm}1.11%$ . 2nd Group (d $V_{diff3%}$ was $1.62{\pm}0.55%$ , PTV was $8.61{\pm}2.01%$ , $V_{diff5%}$ of GTV was 0.0%, PTV was $5.33{\pm}2.32%$ , maximum dose difference rate of bowel_organ was $28.33{\pm}24.41%$ . Conclusion: Despite we saw diaphragm movement more than 5 mm with flouroscopy after use an abdominal compressor, average setup_variation from MVCT was less than 5 mm. Therefore, we could estimate the range of setup_error within a 5 mm. Target's dose difference rate of 1st group ( $d{\geq}1$ ) and 2nd group (d $d{\geq}1$ ) and 2nd group (d】
Cited by 0 works.